Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?

Benzinga · 05/04 15:46
These mid-cap stocks were the best performers in the last week. Are they in your portfolio?
- Pony AI Inc (NASDAQ:PONY) shares were up 48.36% after the company reportedly said it is getting closer to profitability and can build its autonomous driving system for less.
- Hims & Hers Health, Inc. (NYSE:HIMS) stock rocketed 45.32% after the company announced a collaboration with Novo Nordisk A/S (NYSE:NVO) to offer a bundled package of all dose strengths of Wegovy on its platform. B of A Securities analyst raised the price forecast from $22 to $26.
- ODDITY Tech Ltd. (NASDAQ:ODD) shares surged 42.96% after the company reported better-than-expected first-quarter financial results, raised its FY25 guidance, and issued second-quarter guidance above estimates. Analysts raised price forecasts on the stock.
- Metsera, Inc. (NASDAQ:MTSR) stock escalated by 38.42% last week.
- CG Oncology, Inc. (NASDAQ:CGON) stock increased 29.86% after the company announced that cretostimogene grenadenorepvec monotherapy data was presented at the American Urological Association Annual Meeting. Some analysts initiated coverage/ boosted the price forecast.
- Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) shares upped 29.42% after raising its FY25 sales guidance.
- Kingsoft Cloud Holdings Limited (NASDAQ:KC) stock rose 27.34%.
- Frontdoor, Inc. (NASDAQ:FTDR) shares were up 25.44% last week after the company reported better-than-expected first-quarter financial results and raised its FY25 sales outlook.
- ATI Inc. (NYSE:ATI) stock increased 25.39% after it reported better-than-expected quarterly financial results and raised its FY25 adjusted EPS guidance.
- Perdoceo Education Corporation (NASDAQ:PRDO) stock rose 23.72% after it reported first-quarter results.
- iRhythm Technologies, Inc. (NASDAQ:IRTC) stock jumped 23.71% after it reported better-than-expected first-quarter results and raised its FY25 sales guidance.
Photo by Tada Images via Shutterstock
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.